Targeting GCN5-mediated ERK lactylation: A promising drug development frontier in cancer therapy.
Fuente:
PubMed
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artículo científico |
| Lenguaje: | en |
| Publicado: |
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
2026
|
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1868266082221948928 |
|---|---|
| author | Tzeng, Yen-Dun Tony Chiang, An-Jen Li, Chia-Jung |
| author_facet | Tzeng, Yen-Dun Tony Chiang, An-Jen Li, Chia-Jung Tzeng, Yen-Dun Tony Chiang, An-Jen Li, Chia-Jung |
| collection | PubMed - marine biology |
| contents | Targeting GCN5-mediated ERK lactylation: A promising drug development frontier in cancer therapy. Tzeng, Yen-Dun Tony Chiang, An-Jen Li, Chia-Jung |
| format | Artículo científico |
| id | pubmed_41724057 |
| institution | PubMed |
| language | en |
| publishDate | 2026 |
| publisher | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie |
| record_format | pubmed |
| spellingShingle | Targeting GCN5-mediated ERK lactylation: A promising drug development frontier in cancer therapy. Tzeng, Yen-Dun Tony Chiang, An-Jen Li, Chia-Jung Targeting GCN5-mediated ERK lactylation: A promising drug development frontier in cancer therapy. Tzeng, Yen-Dun Tony Chiang, An-Jen Li, Chia-Jung |
| title | Targeting GCN5-mediated ERK lactylation: A promising drug development frontier in cancer therapy. |
| url | https://pubmed.ncbi.nlm.nih.gov/41724057/ |